Ursolic acid induces the production of IL6 and chemokines in both adipocytes and adipose tissue

References

• Ahima RS. Adipose tissue as an endocrine organ. Obesity (Silver Spring). 2006;14(Suppl 5):242S–249S.
   PubMedGoogle Scholar
• Feng B, Jiao P, Nie Y, et al. Clodronate liposomes improve metabolic profile and reduce visceral adipose macrophage content in diet-induced obese mice. PLoS One. 2011;6:e24358.
   PubMed Web of Science ®Google Scholar
• Feng B, Zhang T, Xu H. Human adipose dynamics and metabolic health. Ann N Y Acad Sci. 2013;1281:160–177.
   PubMed Web of Science ®Google Scholar
• Reilly SM, Saltiel AR. Adapting to obesity with adipose tissue inflammation. Nat Rev Endocrinol. 2017;13:633–643.
   PubMed Web of Science ®Google Scholar
• Scherer T, O’Hare J, Diggs-Andrews K, et al. Brain insulin controls adipose tissue lipolysis and lipogenesis. Cell Metab. 2011;13:183–194.
   PubMed Web of Science ®Google Scholar
• Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003;112:1821–1830.
   PubMed Web of Science ®Google Scholar
• Guilherme A, Virbasius JV, Puri V, et al. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol. 2008;9:367–377.
   PubMed Web of Science ®Google Scholar
• Kahn CR, Wang G, Lee KY. Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome. J Clin Invest. 2019;129:3990–4000.
   PubMed Web of Science ®Google Scholar
• Ikeda Y, Murakami A, Ohigashi H. Ursolic acid: an anti- and pro-inflammatory triterpenoid. Mol Nutr Food Res. 2008;52:26–42.
   PubMed Web of Science ®Google Scholar
• Li Y, Kang Z, Li S, et al. Ursolic acid stimulates lipolysis in primary-cultured rat adipocytes. Mol Nutr Food Res. 2010;54:1609–1617.
   PubMed Web of Science ®Google Scholar
• He Y, Li Y, Zhao T, et al. Ursolic acid inhibits adipogenesis in 3T3-L1 adipocytes through LKB1/AMPK pathway. PLoS One. 2013;8:e70135.
   PubMed Web of Science ®Google Scholar
• Li S, Liao X, Meng F, et al. Therapeutic role of ursolic acid on ameliorating hepatic steatosis and improving metabolic disorders in high-fat diet-induced non-alcoholic fatty liver disease rats. PLoS One. 2014;9:e86724.
   PubMed Web of Science ®Google Scholar
• Jia Y, Kim S, Kim J, et al. Ursolic acid improves lipid and glucose metabolism in high-fat-fed C57BL/6J mice by activating peroxisome proliferator-activated receptor alpha and hepatic autophagy. Mol Nutr Food Res. 2015;59:344–354.
   PubMed Web of Science ®Google Scholar
• Ikeda Y, Murakami A, Fujimura Y, et al. Aggregated ursolic acid, a natural triterpenoid, induces IL-1beta release from murine peritoneal macrophages: role of CD36. J Immunol. 2007;178:4854–4864.
   PubMed Web of Science ®Google Scholar
• Ikeda Y, Murakami A, Nishizawa T, et al. Ursolic acid enhances cyclooxygenases and tumor necrosis factor-alpha expression in mouse skin. Biosci Biotechnol Biochem. 2006;70:1033–1037.
   PubMed Web of Science ®Google Scholar
• Chun J, Lee C, Hwang SW, et al. Ursolic acid inhibits nuclear factor-kappaB signaling in intestinal epithelial cells and macrophages, and attenuates experimental colitis in mice. Life Sci. 2014;110:23–34.
   PubMed Web of Science ®Google Scholar
• Kim SH, Hong JH, Lee YC. Ursolic acid, a potential PPARgamma agonist, suppresses ovalbumin-induced airway inflammation and Penh by down-regulating IL-5, IL-13, and IL-17 in a mouse model of allergic asthma. Eur J Pharmacol. 2013;701:131–143.
   PubMed Web of Science ®Google Scholar
• Li J, Li N, Yan S, et al. Ursolic acid alleviates inflammation and against diabetes induced nephropathy through TLR4mediated inflammatory pathway. Mol Med Rep. 2018;18:4675–4681.
   PubMed Web of Science ®Google Scholar
• Zhang T, Su J, Guo B, et al. Ursolic acid alleviates early brain injury after experimental subarachnoid hemorrhage by suppressing TLR4-mediated inflammatory pathway. Int Immunopharmacol. 2014;23:585–591.
   PubMed Web of Science ®Google Scholar
• You HJ, Choi CY, Kim JY, et al. Ursolic acid enhances nitric oxide and tumor necrosis factor-alpha production via nuclear factor-kappaB activation in the resting macrophages. FEBS Lett. 2001;509:156–160.
   PubMed Web of Science ®Google Scholar
• Ma X, Zhang Y, Wang Z, et al. Ursolic acid, a natural nutraceutical agent, targets Caspase3 and alleviates inflammation-associated downstream signal transduction. Mol Nutr Food Res. 2017;61:1700332.
   Web of Science ®Google Scholar
• Jang SE, Jeong JJ, Hyam SR, et al. Ursolic acid isolated from the seed of Cornus officinalis ameliorates colitis in mice by inhibiting the binding of lipopolysaccharide to Toll-like receptor 4 on macrophages. J Agric Food Chem. 2014;62:9711–9721.
   PubMed Web of Science ®Google Scholar
• Ma JQ, Ding J, Zhang L, et al. Ursolic acid protects mouse liver against CCl4-induced oxidative stress and inflammation by the MAPK/NF-kappaB pathway. Environ Toxicol Pharmacol. 2014;37:975–983.
   PubMed Web of Science ®Google Scholar
• Huang X, Jiang D, Zhu Y, et al. Chronic high dose zinc supplementation induces visceral adipose tissue hypertrophy without altering body weight in mice. Nutrients. 2017;9:E1138.
   PubMed Web of Science ®Google Scholar
• Feng B, Huang X, Jiang D, et al. Endoplasmic reticulum stress inducer tunicamycin alters hepatic energy homeostasis in mice. Int J Mol Sci. 2017;18:E1710.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Song C, Li H, et al. Ursolic acid prevents augmented peripheral inflammation and inflammatory hyperalgesia in high-fat diet-induced obese rats by restoring downregulated spinal PPARalpha. Mol Med Rep. 2016;13:5309–5316.
   PubMed Web of Science ®Google Scholar
• Deng X, Zhang W, I OS, et al. FoxO1 inhibits sterol regulatory element-binding protein-1c (SREBP-1c) gene expression via transcription factors Sp1 and SREBP-1c. J Biol Chem. 2012;287:20132–20143.
   PubMed Web of Science ®Google Scholar
• Kanda H, Tateya S, Tamori Y, et al. contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest. 2006;116:1494–1505.
   PubMed Web of Science ®Google Scholar
• Vieira-Potter VJ. Inflammation and macrophage modulation in adipose tissues. Cell Microbiol. 2014;16:1484–1492.
   PubMed Web of Science ®Google Scholar
• Grant RW, Dixit VD. Adipose tissue as an immunological organ. Obesity (Silver Spring). 2015;23:512–518.
   PubMed Web of Science ®Google Scholar
• Checker R, Sandur SK, Sharma D, et al. Potent anti-inflammatory activity of ursolic acid, a triterpenoid antioxidant, is mediated through suppression of NF-kappaB, AP-1 and NF-AT. PLoS One. 2012;7:e31318.
   PubMed Web of Science ®Google Scholar
• Ziraldo C, Vodovotz Y, Namas RA, et al. Central role for MCP-1/CCL2 in injury-induced inflammation revealed by in vitro, in silico, and clinical studies. PLoS One. 2013;8:e79804.
   PubMed Web of Science ®Google Scholar
• Matsubara T, Mita A, Minami K, et al. PGRN is a Key Adipokine Mediating High Fat Diet-Induced Insulin Resistance and Obesity through IL-6 in Adipose Tissue. Cell Metab. 2012;15:38–50.
   PubMed Web of Science ®Google Scholar
• Kim JH, Kim J, Liu H-Y, et al. Regulation of IL-6 induced hepatic insulin resistance by mtor through the STAT3-SOCS3 pathway. J Biol Chem. 283:708–715.
   Google Scholar
• Karimian MS, Pirro M, Majeed M, et al. Curcumin as a natural regulator of monocyte chemoattractant protein-1. Cytokine Growth Factor Rev. 2017;33:55–63.
   PubMed Web of Science ®Google Scholar
• Hayashida K, Nanki T, Girschick H, et al. Synovial stromal cells from rheumatoid arthritis patients attract monocytes by producing MCP-1 and IL-8. Arthritis Res. 2001;3:118–126.
   PubMedGoogle Scholar
• Fernández-Real JM, Pérez Del Pulgar S, Luche E, et al. CD14 modulates inflammation-driven insulin resistance. Diabetes. 2011;60:2179–2186.
   PubMed Web of Science ®Google Scholar
• Luche E, Cousin B, Garidou L, et al. Metabolic endotoxemia directly increases the proliferation of adipocyte precursors at the onset of metabolic diseases through a CD14-dependent mechanism. Mol Metab. 2013;2:281–291.
   PubMed Web of Science ®Google Scholar
• Russo L, Lumeng CN. Properties and functions of adipose tissue macrophages in obesity. Immunology. 2018;155:407–417.
   PubMed Web of Science ®Google Scholar
• Ghosh AK, O’Brien M, Mau T, et al. Toll-like receptor 4 (TLR4) deficient mice are protected from adipose tissue inflammation in aging. Aging (Albany NY). 2017;9:1971–1982.
   PubMedGoogle Scholar
• Thompson WL, Van Eldik LJ. Inflammatory cytokines stimulate the chemokines CCL2/MCP-1 and CCL7/MCP-3 through NFkB and MAPK dependent pathways in rat astrocytes. Brain Res. 2009;1287:47–57.
   PubMed Web of Science ®Google Scholar
• Wu CC, Cheng CH, Lee YH, et al. Ursolic acid triggers apoptosis in human osteosarcoma cells via caspase activation and the ERK1/2 MAPK pathway. J Agric Food Chem. 2016;64:4220–4226.
   PubMed Web of Science ®Google Scholar
• Ito Y, Daitoku H, Foxo FA. increases pro-inflammatory gene expression by inducing C/EBPbeta in TNF-alpha-treated adipocytes. Biochem Biophys Res Commun. 2009;378:290–295.
   PubMed Web of Science ®Google Scholar
• Lafontan M. Adipose tissue and adipocyte dysregulation. Diabetes Metab. 2014;40:16–28.
   PubMed Web of Science ®Google Scholar
• Sundaresan A, Radhiga T, Pugalendi KV. Effect of ursolic acid and Rosiglitazone combination on hepatic lipid accumulation in high fat diet-fed C57BL/6J mice. Eur J Pharmacol. 2014;741:297–303.
   PubMed Web of Science ®Google Scholar
• Kunkel SD, Elmore CJ, Bongers KS, et al. Ursolic acid increases skeletal muscle and brown fat and decreases diet-induced obesity, glucose intolerance and fatty liver disease. PLoS One. 2012;7:e39332.
   PubMed Web of Science ®Google Scholar
• Rao VS, de Melo CL, Queiroz MG, et al. Ursolic acid, a pentacyclic triterpene from Sambucus australis, prevents abdominal adiposity in mice fed a high-fat diet. J Med Food. 2011;14:1375–1382.
   PubMed Web of Science ®Google Scholar
• Sundaresan A, Harini R, Pugalendi KV. Ursolic acid and rosiglitazone combination alleviates metabolic syndrome in high fat diet fed C57BL/6J mice. Gen Physiol Biophys. 2012;31:323–333.
   PubMed Web of Science ®Google Scholar
• Kim JB, Sarraf P, Wright M, et al. Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1/SREBP1. J Clin Invest. 1998;101:1–9.
   PubMed Web of Science ®Google Scholar
• Hagiwara A, Cornu M, Cybulski N, et al. Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c. Cell Metab. 2012;15:725–738.
   PubMed Web of Science ®Google Scholar
• Ma Y, Gao M, Sun H, et al. Interleukin-6 gene transfer reverses body weight gain and fatty liver in obese mice. Biochim Biophys Acta. 2015;1852:1001–1011.
   PubMed Web of Science ®Google Scholar